CFCL Q3 FY2025: Multibagger Agrochemical Stock Set to Surge with TAN Project & Speciality Chemicals Expansion

·

CFCL Q3 FY2025 Result Research Report

Chambal Fertilisers and Chemicals Limited (CFCL) Q3 FY2025 Results

Value Pick Multibagger Stock to buy

Investment Summary

Market Cap: ₹ 22,256 Cr

Current Price: ₹ 556

High/Low: ₹ 575 / 331

Stock P/E: 13.8

Book Value: ₹ 205

Dividend Yield: 1.35%

ROCE: 20.2%

ROE: 17.0%

Face Value: ₹ 10.0

Debt: ₹ 99.4 Cr

Reserves: ₹ 7,803 Cr

Promoter Holding: 60.4%

Sales Growth (YoY): -11.0%

Profit Growth: 26.9%

Sales: ₹ 16,841 Cr

Operating Profit Margin: 14.8%

Q3 FY2025 Financial Performance

Revenue: ₹ 4,918 Cr (13% YoY increase)

EBITDA: ₹ 843 Cr (16% YoY increase)

PBT: ₹ 753 Cr (24% YoY increase)

PAT: ₹ 505 Cr (25% YoY increase)

Consolidated PAT: ₹ 534 Cr (16% YoY increase)

Qtr Sales Variation: 13.1%

3-Year Sales Growth: 12.2%

3-Year Profit Variation: -4.98%

Key Drivers

  • Higher sales volume of Urea & P&K fertilisers
  • Improved energy efficiency & production capacity
  • Strong performance in Crop Protection Chemicals (CPC) & Speciality Nutrients (SN)
  • Improved margins in joint venture IMACID Morocco
  • Strong operational cash flows aiding balance sheet stability

Future Growth Plans & Expansion

1. Technical Ammonium Nitrate (TAN) Project

Investment: ₹ 1,645 Cr

Capacity: 2.4 Lakh MTPA

Amount spent till Dec 31, 2024: ₹ 466 Cr

Current Progress: Civil foundation, detail engineering & major structures near completion

Configuration Changes: Enable additional ammonia feed

Revised Completion Timeline: January 2026 (No cost escalation)

Strategic Rationale: Diversification into industrial chemicals, catering to mining & explosive industries

Revenue Contribution: Estimated annual revenue of ₹ 2,000+ Cr post-commissioning

2. Crop Protection Chemicals (CPC) & Speciality Nutrients (SN) Expansion

Quarterly Growth: 39%

YoY Growth (9 months): 38%

New Territories Revenue Growth: 141%

New Products Launched: 12 (weedicide, fungicide & insecticide)

Focus Areas: Biologicals (Mycorrhiza biofertilizers, bio-nematicides, bio-fungicides)

Revenue Target by FY26-27: ₹ 1,750 Cr (from ₹ 760 Cr in FY24)

Strategic Alliances: Collaborations with Japanese, US & European firms

New Market Entry: Africa & South-East Asia

3. CFCL-TERI Centre of Excellence

Collaboration: The Energy and Resources Institute (TERI)

Focus Areas: Sustainable agriculture solutions, nano-biotechnology, bio-stimulants & biopesticides

Alignment: PM PRANAAM scheme promoting biofertilizers

Goal: Reduce chemical fertilizer dependency by 20% over 5 years

4. Digital & Market Expansion Initiatives

Farmer Education: Seed to Harvest program

Support: ‘Hello Uttam Experts’ farmer call center

Domestic B2C Market Target: ₹ 10,500 Cr by FY26-27

Retail Expansion: Increased distributor network by 15% YoY

Competitive Landscape & Risks

Competitive Positioning

  • Largest private Urea manufacturer in India
  • Diversified portfolio covering Urea, P&K fertilisers, CPC & SN
  • Strong farmer outreach programs enhancing brand loyalty
  • Emerging Player in TAN Segment with competitive advantage

Key Risks

  • Regulatory Dependence: Government pricing & subsidy policies impact margins
  • Raw Material Volatility: Dependency on imported raw materials
  • Delayed TAN Project Execution: Potential impact on future revenue projections
  • Competition: Increasing market presence of domestic & international agrochemical players
  • Environmental & ESG Concerns: Stricter pollution norms could impact manufacturing costs

Valuation & Investment Thesis

P/E Ratio: 13.8 (Fairly valued compared to peers)

ROE: 17.0%

ROCE: 20.2%

Debt: Low at ₹ 99.4 Cr

Dividend Yield: 1.35%

Urea Demand: Expected to remain steady

CPC & SN Growth: >20% CAGR over next 3 years

Long-term Goal: Market leadership in sustainable agrochemical solutions

Investment Verdict: Moderate Buy

  • Strong fundamentals with diversified product portfolio
  • Expansion in high-margin CPC & SN business is a key positive
  • Risk: Dependency on government policies & regulatory changes
  • Valuation: Fairly priced with scope for future growth

Disclaimer

This report is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence before making investment decisions. Stock market investments are subject to market risks. Past performance does not guarantee future results.

© 2025 Stock Research Report. All Rights Reserved.

Value Picks fin.ctoi.in
Value Picks fin.ctoi.in
Value Picks

Dont Miss our Value picks

SUBSCRIBE TO OUR NEWSLETTER to Get short term, long term and multi-bagger

We don’t spam! Read our privacy policy for more info.

Value Picks fin.ctoi.in
Value Picks fin.ctoi.in
Value Picks

Dont Miss our Value picks

SUBSCRIBE TO OUR NEWSLETTER to Get short term, long term and multi-bagger

We don’t spam! Read our privacy policy for more info.

Comments

Leave a Reply